Tumors after radiotherapy for thyroid cancer. A case-control study within a cohort of thyroid cancer patients.
A case-control study of Swedish thyroid cancer patients was conducted to evaluate the possible influence of 131I treatment and external radiotherapy on the risk of developing a subsequent cancer. Both cases and controls derived from a cohort of Swedish thyroid cancer patients treated with 131I (n = 834) or by other means (n = 1,121). Thirty-six breast, 13 stomach, 12 kidney, and 5 bladder cancers were found more than 2 years after 131I treatment/thyroid cancer diagnosis. Individual, absorbed dose in the organs was calculated by using ICRP tables, administered activity of 131I, and 24-h 131I uptake. In studying the effect of 131I and external radiotherapy no statistically significant dose-response relationships were found for cancers of the breast, stomach, bladder or kidney. When the absorbed dose from 131I was analyzed separately the risks remained essentially the same. The present follow-up time and the relatively low absorbed dose that the patients received from 131I and external radiotherapy necessitate studies with a longer follow-up time or a larger patient material before more firm conclusions can be made.
Hall
P
P
Department of General Oncology, Karolinska Hospital, Stockholm, Sweden.
Holm
L E
LE
Lundell
G
G
Rudén
B I
BI
D000293:Adolescent; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000209:etiology; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D011879:Radiotherapy Dosage; D013274:Stomach Neoplasms / Q000209:etiology; D013548:Sweden; D013964:Thyroid Neoplasms / Q000532:radiotherapy*; D001749:Urinary Bladder Neoplasms / Q000209:etiology
D007457:Iodine Radioisotopes